ASCO: Afinitor Quells Herceptin Resistance

CHICAGO (MedPage Today) -- A study presented here may help unravel the issue of resistance to trastuzumab (Herceptin), a drug that is central to the treatment of HER2-positive breast cancer. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/asco-afinitor-quells-herceptin.html